151 related articles for article (PubMed ID: 12215381)
21. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
22. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.
Thurner B; Röder C; Dieckmann D; Heuer M; Kruse M; Glaser A; Keikavoussi P; Kämpgen E; Bender A; Schuler G
J Immunol Methods; 1999 Feb; 223(1):1-15. PubMed ID: 10037230
[TBL] [Abstract][Full Text] [Related]
23. In vitro production of dendritic cells from human blood monocytes for therapeutic use.
Garderet L; Cao H; Salamero J; Vergé V; Tisserand E; Scholl S; Gorin NC; Lopez M
J Hematother Stem Cell Res; 2001 Aug; 10(4):553-67. PubMed ID: 11522238
[TBL] [Abstract][Full Text] [Related]
24. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
[TBL] [Abstract][Full Text] [Related]
25. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes.
Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I
Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569
[TBL] [Abstract][Full Text] [Related]
26. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
Ponsaerts P; Van den Bosch G; Cools N; Van Driessche A; Nijs G; Lenjou M; Lardon F; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunol; 2002 Aug; 169(4):1669-75. PubMed ID: 12165485
[TBL] [Abstract][Full Text] [Related]
27. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
[TBL] [Abstract][Full Text] [Related]
28. Analysis of methods for the generation of dendritic cells from human peripheral blood monocytes.
Choi GS; Kang JM; Lee MG
Yonsei Med J; 2000 Oct; 41(5):642-50. PubMed ID: 11079625
[TBL] [Abstract][Full Text] [Related]
29. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.
Morse MA; Zhou LJ; Tedder TF; Lyerly HK; Smith C
Ann Surg; 1997 Jul; 226(1):6-16. PubMed ID: 9242332
[TBL] [Abstract][Full Text] [Related]
30. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
[TBL] [Abstract][Full Text] [Related]
31. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
32. A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.
Guan X; Peng JR; Yuan L; Wang H; Wei YH; Leng XS
World J Gastroenterol; 2004 Dec; 10(24):3564-8. PubMed ID: 15534907
[TBL] [Abstract][Full Text] [Related]
33. Fast monocyte-derived dendritic cell-based immunotherapy.
Ramadan G
Methods Mol Biol; 2014; 1139():131-44. PubMed ID: 24619676
[TBL] [Abstract][Full Text] [Related]
34. Simplified method to generate large quantities of dendritic cells suitable for clinical applications.
Goxe B; Latour N; Chokri M; Abastado JP; Salcedo M
Immunol Invest; 2000 Aug; 29(3):319-36. PubMed ID: 10933613
[TBL] [Abstract][Full Text] [Related]
35. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.
Hutten T; Thordardottir S; Hobo W; Hübel J; van der Waart AB; Cany J; Dolstra H; Hangalapura BN
J Immunother; 2014 Jun; 37(5):267-77. PubMed ID: 24810638
[TBL] [Abstract][Full Text] [Related]
37. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro].
Tang JF; Guan SH; Wang ZG
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216
[TBL] [Abstract][Full Text] [Related]
38. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
39. Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy.
Erdmann M; Uslu U; Wiesinger M; Brüning M; Altmann T; Strasser E; Schuler G; Schuler-Thurner B
J Immunol Methods; 2018 Dec; 463():89-96. PubMed ID: 30266448
[TBL] [Abstract][Full Text] [Related]
40. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
Canque B; Camus S; Yagello M; Gluckman JC
J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
